The new schizophrenia drug didn’t provide additional benefits when given on top of standard-of-care therapy, Bristol Myers ...

"This research shows that when antipsychotic drugs are formulated with our new smart core-shell microparticles, drug absorption increases, mitigating the need for the medication to be consumed ...

(Reuters) -Bristol Myers Squibb said on Tuesday its drug Cobenfy failed to show a statistically significant difference in a ...

A recent study by researchers at Rutgers University and Columbia University has found a serious link between certain mental ...

The FDA approval of Alkermes' new antipsychotic drug Lybalvi couldn't have gone any better for the company, but it could still face a big challenge positioning the new drug in the highly ...

D.J. became one of the first in line to try the new antipsychotic, called Cobenfy — a potentially life-changing drug for one of psychiatry’s most intractable mental illnesses, but whose long-term side ...

Antipsychotic medications were identified from pharmacy claims closest to the index date (±90 days). All first-generation (FGA) and second-generation (SGA) antipsychotics were included.

New information is shedding light on how antipsychotics prescribing ... People with these symptoms are often prescribed antipsychotic drugs inappropriately. These may reduce experiences such as ...

Members of a national coalition are urging HHS and CMS to revisit what they’ve deemed a flawed measure in CMS’ Five-Star Rating System.